Clomicalm

RSS

Clomipramine

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Clomicalm. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Clomicalm.

For practical information about using Clomicalm, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 04/03/2020

Authorisation details

Product details
Name
Clomicalm
Agency product number
EMEA/V/C/000039
Active substance
clomipramine
International non-proprietary name (INN) or common name
Clomipramine
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QN06AA04
Publication details
Marketing-authorisation holder
Elanco GmbH
Revision
16
Date of issue of marketing authorisation valid throughout the European Union
01/04/1998
Contact address

Heinz-Lohmann-Str 4
27472 Cuxhaven
Germany

Product information

13/12/2019 Clomicalm - EMEA/V/C/000039 - IB/0034/G

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Psychoanaleptics

Therapeutic indication

As an aid in the treatment of separation-related disorders in dogs manifested by destruction and inappropriate elimination (defaecation and urination) and only in combination with behavioural modification techniques.

Assessment history

How useful was this page?

Add your rating